Literature DB >> 2581926

The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria.

H Irschik, R Jansen, G Höfle, K Gerth, H Reichenbach.   

Abstract

From the culture broth of the myxobacterium, Corallococcus (Myxococcus) coralloides, three new antibiotics have been isolated: corallopyronin A, B and C. The compounds, which are chemically related to the recently discovered myxopyronins, act mainly on Gram-positive bacteria, with MIC values between 0.1 and 10 micrograms/ml, and only exceptionally or at much higher concentrations (MIC values; 100 and more micrograms/ml) on Gram-negatives. They do not inhibit eukaryotic organisms and show no toxicity for mice (sc). The corallopyronins appear to block specifically eubacterial RNA polymerase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581926     DOI: 10.7164/antibiotics.38.145

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  26 in total

1.  RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.

Authors:  A O'Neill; B Oliva; C Storey; A Hoyle; C Fishwick; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Influence of DNA template choice on transcription and inhibition of Escherichia coli RNA polymerase.

Authors:  Joerg Haupenthal; Kristina Hüsecken; Matthias Negri; Christine K Maurer; Rolf W Hartmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 3.  Bacterial Transcription as a Target for Antibacterial Drug Development.

Authors:  Cong Ma; Xiao Yang; Peter J Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-13       Impact factor: 11.056

4.  Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymerase.

Authors:  Katherine Mariner; Martin McPhillie; Rachel Trowbridge; Catriona Smith; Alex J O'Neill; Colin W G Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

5.  Germicidins H-J from Streptomyces sp. CB00361.

Authors:  Ming Ma; Mostafa E Rateb; Dong Yang; Jeffrey D Rudolf; Xiangcheng Zhu; Yong Huang; Li-Xing Zhao; Yi Jiang; Yanwen Duan; Ben Shen
Journal:  J Antibiot (Tokyo)       Date:  2016-08-10       Impact factor: 2.649

6.  Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.

Authors:  Sonia I Maffioli; Yu Zhang; David Degen; Thomas Carzaniga; Giancarlo Del Gatto; Stefania Serina; Paolo Monciardini; Carlo Mazzetti; Paola Guglierame; Gianpaolo Candiani; Alina Iulia Chiriac; Giuseppe Facchetti; Petra Kaltofen; Hans-Georg Sahl; Gianni Dehò; Stefano Donadio; Richard H Ebright
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

7.  Antibiotic production by myxobacteria plays a role in predation.

Authors:  Yao Xiao; Xueming Wei; Richard Ebright; Daniel Wall
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

8.  Orientia tsutsugamushi Is Highly Susceptible to the RNA Polymerase Switch Region Inhibitor Corallopyronin A In Vitro and In Vivo.

Authors:  Fredericke Kock; Matthias Hauptmann; Anke Osterloh; Till F Schäberle; Sven Poppert; Hagen Frickmann; Klaus-Dieter Menzel; Gundela Peschel; Kenneth Pfarr; Andrea Schiefer; Gabriele M König; Achim Hoerauf; Bernhard Fleischer; Christian Keller
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

9.  Soil myxobacteria as a potential source of polyketide-peptide substances.

Authors:  Ivana Charousová; Heinrich Steinmetz; Juraj Medo; Soňa Javoreková; Joachim Wink
Journal:  Folia Microbiol (Praha)       Date:  2017-02-04       Impact factor: 2.099

10.  Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.

Authors:  Andrea Schiefer; Alexander Schmitz; Till F Schäberle; Sabine Specht; Christine Lämmer; Kelly L Johnston; Dmitry G Vassylyev; Gabriele M König; Achim Hoerauf; Kenneth Pfarr
Journal:  J Infect Dis       Date:  2012-05-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.